bioAffinity Technologies, Inc.
BIAF
$0.4698
-$0.0292-5.85%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -6.08% | -1.97% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.08% | -1.97% | |||
| Cost of Revenue | 8.47% | 2.31% | |||
| Gross Profit | -29.09% | -8.05% | |||
| SG&A Expenses | 23.50% | -4.38% | |||
| Depreciation & Amortization | 1.52% | 0.13% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 19.19% | -3.59% | |||
| Operating Income | -49.28% | 5.46% | |||
| Income Before Tax | -48.47% | 5.06% | |||
| Income Tax Expenses | -100.00% | -51.85% | |||
| Earnings from Continuing Operations | -48.29% | 5.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -48.29% | 5.19% | |||
| EBIT | -49.28% | 5.46% | |||
| EBITDA | -53.24% | 5.89% | |||
| EPS Basic | -24.21% | 12.84% | |||
| Normalized Basic EPS | -24.40% | 12.73% | |||
| EPS Diluted | -24.21% | 12.84% | |||
| Normalized Diluted EPS | -24.40% | 12.73% | |||
| Average Basic Shares Outstanding | 19.34% | 8.80% | |||
| Average Diluted Shares Outstanding | 19.34% | 8.80% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||